Trials / Completed
CompletedNCT01177254
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (actual)
- Sponsor
- NEMA Research, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Using a retrospective analysis of a large commercial claims database and a Medicare database, the investigators evaluated DDEs that have the potential to cause DDIs among chronic low back pain (cLBP) patients on long-term opioid analgesia, which metabolizes through the CYP450 enzyme system, concomitant with other CYP450-metabolized drug(s).
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2010-12-01
- Completion
- 2011-02-01
- First posted
- 2010-08-06
- Last updated
- 2012-05-01
Source: ClinicalTrials.gov record NCT01177254. Inclusion in this directory is not an endorsement.